PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 4, 2026Proceedings of the National Academy of Sciences2 citations

Extended local anesthesia enabled by flavonoid permeation enhancers

View Full Paper
YHYiyuan HanMTMatthew TorreWHWeiling He

Key Points

  • To explore the potential of flavonoids as permeation enhancers that prolong the effects of sodium channel blockers in local anesthesia.
  • Investigated the effects of puerarin, naringenin, and kaempferol on nerve block duration.
  • Utilized tympanic membrane permeation and sciatic nerve fluorescence distribution models for assessment.
  • Developed a liposomal delivery system for coencapsulating TTX and puerarin.
  • Flavonoids prolonged nerve block duration from sodium channel blockers by 4 to 25-fold.
  • Demonstrated minimal tissue toxicity compared to conventional permeation enhancers.
  • Achieved over 25 days of local anesthesia with the liposomal delivery of TTX and puerarin.

Abstract

Site 1 sodium channel blockers (S1SCBs), such as tetrodotoxin (TTX) and neosaxitoxin, are ultrapotent local anesthetics with low tissue toxicity. Their duration of action is relatively brief, but increasing the dose can lead to systemic toxicity. Here, we report that selected flavonoids—puerarin (PUE), naringenin, and kaempferol—prolong nerve block from S1SCBs 4- to 25-fold. Using both tympanic membrane (TM) permeation and sciatic nerve fluorescence distribution models, we demonstrate the flavonoids increase drug penetration across biological barriers (the TM and the barriers in and around nerve), suggesting that they act as chemical permeation enhancers (CPEs). Importantly, flavonoids exhibited minimal tissue toxicity compared to conventional CPEs. Coencapsulation of TTX and PUE into a liposomal delivery system further prolonged local anesthesia to over 25 d from a single injection. These findings establish flavonoid compounds as a safe class of CPEs and provide a platform of long-acting, nonopioid pain therapies. Flavonoids may be attractive alternatives to conventional CPEs in biomedical applications.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Han et al. (2026) studied this question.

synapsesocial.com/papers/69a7cc8ed48f933b5eed839bhttps://doi.org/10.1073/pnas.2523195123
Ask AI
Helpful
Bookmark
Share
View Full Paper